Membership Directory - Corporate

Technical & Management Services Pty Ltd

Biotechnology

About

Available to Members
Province: New South Wales
Company Overview: TMS is the Beasley group family office - our key investments are in life sciences, namely in novel cancer immunotherapy R&D (via Melbourne-based Myrio Therapeutics) and in a novel point-of-care blood diagnostic R&D business (via Melbourne-based EQi Bio). We are currently engaging in capital raisings for both Myrio Therapeutics and EQi Bio.
Year Founded: 1997
Company Size: 11-50 employees

Members

Investor Relations